<DOC>
	<DOCNO>NCT02722603</DOCNO>
	<brief_summary>This study evaluate efficacy safety gabapentin relative tramadol treatment chronic , neuropathic mixed pain paediatric population . Children 3 month le 18 year age experience moderate severe chronic pain receive either gabapentin tramadol 15 week . The difference average pain score treatment arm end treatment period assess .</brief_summary>
	<brief_title>Study Compare Gabapentin Tramadol Children</brief_title>
	<detailed_description>Gabapentin indicate treatment peripheral neuropathic pain adult . In absence specific paediatric study , approve condition child . The paediatric use gabapentin hamper ) lack suitable paediatric formulation , b ) significant variability gabapentin PK profile c ) efficacy safety data specific population . The GABA-1 study design demonstrate efficacy gabapentin oral solution relative tramadol document PK safety profile gabapentin indication . GABA-1 non-inferiority trial gabapentin expect equally effective well tolerate tramadol , thus provide clinical benefit affect child .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>subject neuropathic mixed chronic pain subject least moderate pain ( pain intensity â‰¥4/10 assess ageappropriate pain scale ) subject stable underlying disease condition treatment . pain duration 5 year current use gabapentin tramadol history failure respond adequate treatment gabapentin tramadol/opioids neuropathic pain .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>